These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36651624)

  • 21. Prospective study on resting state functional connectivity in adolescents with major depressive disorder after antidepressant treatment.
    Chi S; Song M; Lee JH; Ko M; Suh SI; Lee MS
    J Psychiatr Res; 2021 Oct; 142():369-375. PubMed ID: 34425489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression.
    Segal ZV; Bieling P; Young T; MacQueen G; Cooke R; Martin L; Bloch R; Levitan RD
    Arch Gen Psychiatry; 2010 Dec; 67(12):1256-64. PubMed ID: 21135325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of Cognitive-Behavioral Therapy for Insomnia Combined With Antidepressant Pharmacotherapy in Patients With Comorbid Depression and Insomnia: A Randomized Controlled Trial.
    Manber R; Buysse DJ; Edinger J; Krystal A; Luther JF; Wisniewski SR; Trockel M; Kraemer HC; Thase ME
    J Clin Psychiatry; 2016 Oct; 77(10):e1316-e1323. PubMed ID: 27788313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative effectiveness of continuation and maintenance treatments for persistent depressive disorder in adults.
    Machmutow K; Meister R; Jansen A; Kriston L; Watzke B; Härter MC; Liebherz S
    Cochrane Database Syst Rev; 2019 May; 5(5):CD012855. PubMed ID: 31106850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrinsic functional connectivity predicts remission on antidepressants: a randomized controlled trial to identify clinically applicable imaging biomarkers.
    Goldstein-Piekarski AN; Staveland BR; Ball TM; Yesavage J; Korgaonkar MS; Williams LM
    Transl Psychiatry; 2018 Mar; 8(1):57. PubMed ID: 29507282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of escitalopram therapy on resting-state functional connectivity of subsystems of the default mode network in unmedicated patients with major depressive disorder.
    Cui J; Wang Y; Liu R; Chen X; Zhang Z; Feng Y; Zhou J; Zhou Y; Wang G
    Transl Psychiatry; 2021 Dec; 11(1):634. PubMed ID: 34903712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resting state functional connectivity patterns as biomarkers of treatment response to escitalopram in patients with major depressive disorder.
    Martens MAG; Filippini N; Harmer CJ; Godlewska BR
    Psychopharmacology (Berl); 2022 Nov; 239(11):3447-3460. PubMed ID: 34477887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial.
    Wiles N; Thomas L; Abel A; Barnes M; Carroll F; Ridgway N; Sherlock S; Turner N; Button K; Odondi L; Metcalfe C; Owen-Smith A; Campbell J; Garland A; Hollinghurst S; Jerrom B; Kessler D; Kuyken W; Morrison J; Turner K; Williams C; Peters T; Lewis G
    Health Technol Assess; 2014 May; 18(31):1-167, vii-viii. PubMed ID: 24824481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. REVAMP - Research Evaluating the Value of Augmenting Medication with Psychotherapy: rationale and design.
    Trivedi MH; Kocsis JH; Thase ME; Morris DW; Wisniewski SR; Leon AC; Gelenberg AJ; Klein DN; Niederehe G; Schatzberg AF; Ninan PT; Keller MB
    Psychopharmacol Bull; 2008; 41(4):5-33. PubMed ID: 19015627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anterior cingulate volume predicts response to psychotherapy and functional connectivity with the inferior parietal cortex in major depressive disorder.
    Sambataro F; Doerig N; Hänggi J; Wolf RC; Brakowski J; Holtforth MG; Seifritz E; Spinelli S
    Eur Neuropsychopharmacol; 2018 Jan; 28(1):138-148. PubMed ID: 29239789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multidimensional prediction of treatment response to antidepressants with cognitive control and functional MRI.
    Crane NA; Jenkins LM; Bhaumik R; Dion C; Gowins JR; Mickey BJ; Zubieta JK; Langenecker SA
    Brain; 2017 Feb; 140(2):472-486. PubMed ID: 28122876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Appalachia Mind Health Initiative (AMHI): a pragmatic randomized clinical trial of adjunctive internet-based cognitive behavior therapy for treating major depressive disorder among primary care patients.
    Bossarte RM; Kessler RC; Nierenberg AA; Chattopadhyay A; Cuijpers P; Enrique A; Foxworth PM; Gildea SM; Belnap BH; Haut MW; Law KB; Lewis WD; Liu H; Luedtke AR; Pigeon WR; Rhodes LA; Richards D; Rollman BL; Sampson NA; Stokes CM; Torous J; Webb TD; Zubizarreta JR
    Trials; 2022 Jun; 23(1):520. PubMed ID: 35725644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful group psychotherapy of depression in adolescents alters fronto-limbic resting-state connectivity.
    Straub J; Metzger CD; Plener PL; Koelch MG; Groen G; Abler B
    J Affect Disord; 2017 Feb; 209():135-139. PubMed ID: 27912160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Baseline patterns of resting functional connectivity within posterior default-mode intranetwork associated with remission to antidepressants in major depressive disorder.
    Ye Y; Wang C; Lan X; Li W; Fu L; Zhang F; Liu H; Wu K; Zhou Y; Ning Y
    Neuroimage Clin; 2022; 36():103230. PubMed ID: 36274375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial.
    Kocsis JH; Gelenberg AJ; Rothbaum BO; Klein DN; Trivedi MH; Manber R; Keller MB; Leon AC; Wisniewski SR; Arnow BA; Markowitz JC; Thase ME;
    Arch Gen Psychiatry; 2009 Nov; 66(11):1178-88. PubMed ID: 19884606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of cognitive behavioral therapy on resting-state functional brain network in drug-naive patients with obsessive-compulsive disorder.
    Li P; Yang X; Greenshaw AJ; Li S; Luo J; Han H; Liu J; Zhong Z; Guo Z; Xiong H; Yao S; Chen Y; Sun J; Li Z
    Brain Behav; 2018 May; 8(5):e00963. PubMed ID: 29761016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pretreatment regional brain glucose uptake in the midbrain on PET may predict remission from a major depressive episode after three months of treatment.
    Milak MS; Parsey RV; Lee L; Oquendo MA; Olvet DM; Eipper F; Malone K; Mann JJ
    Psychiatry Res; 2009 Jul; 173(1):63-70. PubMed ID: 19446443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of Recurrence After Recovery From a Major Depressive Episode With Antidepressant Medication Alone or in Combination With Cognitive Behavioral Therapy: Phase 2 of a 2-Phase Randomized Clinical Trial.
    DeRubeis RJ; Zajecka J; Shelton RC; Amsterdam JD; Fawcett J; Xu C; Young PR; Gallop R; Hollon SD
    JAMA Psychiatry; 2020 Mar; 77(3):237-245. PubMed ID: 31799993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Follow-up of monotherapy remitters in the PReDICT study: Maintenance treatment outcomes and clinical predictors of recurrence.
    Kennedy JC; Dunlop BW; Craighead LW; Nemeroff CB; Mayberg HS; Craighead WE
    J Consult Clin Psychol; 2018 Feb; 86(2):189-199. PubMed ID: 29369664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.